Mutational Analysis of the Müllerian-Inhibiting Substance Gene and Its Receptor Gene in Japanese Women with Polycystic Ovary Syndrome and Premature Ovarian Failure
Hua-Qin Wang,Kenji Takakura,Koichi Takebayashi,Yoichi Noda
DOI: https://doi.org/10.1016/s0015-0282(02)04351-0
IF: 6.7
2002-01-01
Fertility and Sterility
Abstract:The müllerian-inhibiting substance (MIS) gene and the MIS receptor type II gene were evaluated as candidate genes for premature ovarian failure and polycystic ovary syndrome. Direct sequencing revealed no causative mutations in the coding regions of these genes. Müllerian-inhibiting substance (MIS), also known as anti-müllerian hormone, is a member of the transforming growth factor-β (TGF-β) superfamily (1Cate R.L. Mattaliano R.J. Hession C. Tizard R. Farber N.M. Cheung A. et al.Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells.Cell. 1986; 45: 685-698Abstract Full Text PDF PubMed Scopus (782) Google Scholar) and is secreted specifically by the immature Sertoli cells of the testis and the granulosa cells of the ovary in humans (2Rajpert-De Meyts E. Jørgensen N. Græm N. Muller J. Cate R.L. Skakkebæk N.E. Expression of anti-müllerian hormone during normal and pathological gonadal development association with differentiation of Sertoli and granulosa cells.J Clin Endocrinol Metab. 1999; 84: 3836-3844Crossref PubMed Scopus (357) Google Scholar). MIS is a testicular hormone responsible for müllerian duct regression in male sexual development and acts as an oocyte meiosis inhibitor in the rat ovary (3Takahashi M. Koide S.S. Donahoe P.K. Müllerian inhibiting substance as oocyte meiosis inhibitor.Mol Cell Endocrinol. 1986; 47: 225-234Crossref PubMed Scopus (101) Google Scholar, 4Ueno S. Manganaro T.F. Donahoe P.K. Human recombinant müllerian inhibiting substance inhibition of rat oocyte meiosis is reversed by epidermal growth factor in vitro.Endocrinology. 1988; 123: 1652-1659Crossref PubMed Scopus (78) Google Scholar). In mice, MIS null females are fertile and have macroscopically normal uteri, oviducts, and ovaries. However, such mice have recently been shown to have an increased number of growing preantral follicles during early adulthood and to undergo earlier reproductive senescence possibly because of an early depletion of their stock of primordial follicles (5Durlinger A.L.L. Kramer P. Karels B. de Jong F.H. Uilenbroek J.T.J. Grootegoed J.A. et al.Control of primordial follicle recruitment by anti-müllerian hormone in the mouse ovary.Endocrinology. 1999; 140: 5789-5796Crossref PubMed Scopus (572) Google Scholar). On the other hand, MIS receptor type II is also expressed in granulosa cells of mainly nonatretic preantral and small antral follicles (6Imbeaud S. Faure E. Lamarre I. Mattei M.G. di Clemente N. Tizard R. et al.Insensitivity to anti-müllerian hormone due to a mutation in the human anti-müllerian hormone receptor.Nature Genet. 1995; 11: 382-388Crossref PubMed Scopus (196) Google Scholar), whereas the signal is lost in nonatretic large antral follicles and atretic follicles of all size classes (7Baarends W.M. Uilenbroek J.T.J. Kramer P. Hoogerbrugge J.W. van Leeuwen E.C. Themmen A.P. et al.Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth.Endocrinology. 1995; 136: 4951-4962Crossref PubMed Google Scholar). Through these rodent models, we speculated that the impaired MIS signaling might cause ovarian dysfunction in humans, resulting in premature ovarian failure (POF) or polycystic ovary syndrome (PCOS) in phenotype. Therefore, we examined whether the unique alterations in the MIS and MIS receptor type II genes are present in Japanese women with 46,XX POF and PCOS. This study was approved by the Institutional Review Board of Shiga University of Medical Science. Informed consents were obtained from all patients and controls. Fifty-nine unrelated women with a history of infertility were recruited for this study. The age at presentation ranged from 20 to 37 years. Of these 59 patients, 16 patients were diagnosed as idiopathic POF, defined as secondary amenorrhea before 40 years of age with elevated gonadotropins on at least two occasions (with FSH: 97.9 ± 8.9 mIU/mL and LH: 39.0 ± 15.3 mIU/mL; mean ± SD). The reference range for FSH is 2.0–14.8 mIU/mL, and values above 40 mIU/mL are indicative of ovarian failure. Secondary amenorrhea was defined as absence of menstruation for at least 6 months. Each patient's medical history was taken and each underwent a physical examination to rule out any identifiable cause of POF. Forty-three patients were diagnosed with PCOS according to the following criteria of the Japan Society of Obstetrics and Gynecology: [1] amenorrhea or oligomenorrhea without specific underlying diseases of the adrenal or pituitary glands; [2] a high basal LH level and a high LH-to-FSH ratio (>3.0); and [3] bilaterally enlarged ovaries with multiple small cysts as assessed by transvaginal ultrasonography. Although hyperandrogenemia or androgenic manifestations were not regarded as essential criteria, patients having increased hair growth of the masculine pattern on any of the face, chest, abdomen, pubic region, or legs were recorded as hirsute. Twelve normally menstruating, fertile, unrelated women between 27 and 40 years and 8 fertile men between 27 and 47 years were selected and studied as fertile control subjects. Genomic DNA was extracted from peripheral leukocytes with QIAamp DNA Blood Kit (QIAGEN, Hilden, Germany) according to the manufacturer's instructions. The coding regions of the MIS and the MIS receptor type II genes were amplified from genomic DNA by polymerase chain reaction (PCR). Five pairs of primers were used to amplify the coding sequence of the MIS gene, and 8 pairs of primers were used to amplify the coding sequence of the MIS receptor type II gene. In every reaction, a negative control containing all reagents except DNA was included. The purified PCR products were subjected to direct sequencing in the bilateral direction as previously reported (8Takebayashi K. Takakura K. Wang H.-Q. Kimura F. Kasahara K. Noda Y. Mutation analysis of the growth differentiation factor-9 and -9B genes in patients with premature ovarian failure and polycystic ovary syndrome.Fertil Steril. 2000; 74: 976-979Abstract Full Text Full Text PDF PubMed Scopus (88) Google Scholar). Results were analyzed using χ2 test and P<.05 was considered statistically significant. Polymerase chain reaction was performed against all the coding sequence of the MIS and the MIS receptor type II genes. Agarose gel electrophoresis of PCR products amplified from all 79 subjects revealed no discernible differences between controls and patients with POF and PCOS. To detect small gene deletions or point mutations, we performed direct sequencing. As a result, direct sequencing failed to reveal any variants in the coding regions of the MIS receptor type II gene, however, we found five point mutations (T156G, G262A, G326A, G1148A, and A2191T) in the coding regions of the MIS gene (Table 1). Of all 79 subjects, the T156G (Ile49Ser) variant was observed in 39 subjects composed of 10 (9 heteroallelic and 1 homoallelic) of 16 POF patients, 19 (15 heteroallelic and 4 homoallelic) of 43 PCOS patients, and 10 (9 heteroallelic and 1 homoallelic) of 20 controls. The frequency of this variant among the groups was statistically not significant (P>.05). The G326A (Gly106Ser) variant was observed in one PCOS patient as a heteroallelic variant. The G262A variant was observed in 7 subjects composed of 2 POF patients, 3 PCOS patients, and 2 controls. All of them were the heteroallelic variant. The G1148A variant was observed in 20 subjects composed of 5 POF patients, 10 PCOS patients, and 5 controls. All of them were the heteroallelic variant, except for one POF patient. The A2191T variant was observed in 10 subjects composed of 7 PCOS patients and 3 controls. All of them were the heteroallelic variant.TABLE 1Base changes observed in the MIS gene in patients with PCOS or POF and normal fertile controlHuman MIS geneBase changeAmino acid changeNumber with indicated substitutionPCOS (n = 43)POF (n = 16)Control (n = 20)Exon 1T156GIle49Ser191010G262Asilent322G326AGly106Ser100Exon 2G1148Asilent1055Exon 5A2191Tsilent703Numbering of the oligonucleotides is according to reference 1Cate R.L. Mattaliano R.J. Hession C. Tizard R. Farber N.M. Cheung A. et al.Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells.Cell. 1986; 45: 685-698Abstract Full Text PDF PubMed Scopus (782) Google Scholar. Amino acid residues are numbered from the initiating methionine.Wang. MIS and MISRII mutations in POF and PCOS.Fertil Steril 2002. Open table in a new tab Numbering of the oligonucleotides is according to reference 1Cate R.L. Mattaliano R.J. Hession C. Tizard R. Farber N.M. Cheung A. et al.Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells.Cell. 1986; 45: 685-698Abstract Full Text PDF PubMed Scopus (782) Google Scholar. Amino acid residues are numbered from the initiating methionine. Wang. MIS and MISRII mutations in POF and PCOS.Fertil Steril 2002. The pathogenesis of PCOS and POF is poorly understood. In the present study, we examined the whole coding regions of the MIS gene and the MIS receptor type II gene in 16 POF patients, 43 PCOS patients, and 20 controls by direct sequencing. We detected two missense (T156G and G326A) variants and three silent variants (G262A, G1148A, and A2191T) in the MIS gene, whereas we could not detect any variations in the coding regions of the MIS receptor type II gene. The T156G (Ile49Ser) variant seems to be not biologically significant because it was also found in half of the controls. Judging from the frequency, despite the small number in this study, we speculate that this T156G variation in the MIS gene may be common at least in the Japanese population. On the other hand, the G326A (Gly106Ser) variant was observed in only one PCOS patient as a heteroallelic variant. It is not known whether this variant is functionally significant. Thus far all polymorphisms that we found in this study, except for G326A, have already been reported in male subjects (9Imbeaud S. Carre-Eusebe D. Rey R. Belville C. Josso N. Picard J.-Y. Molecular genetics of the persistent müllerian duct syndrome a study of 19 families.Hum Mol Genet. 1994; 3: 125-131Crossref PubMed Scopus (97) Google Scholar). To our knowledge, however, the current study is the first to evaluate the genes for both MIS and its receptor in 46,XX females with ovulatory disorders. Although the number of patients evaluated was small and we cannot exclude the presence of mutations in other regions, for example, the promoter region, of the MIS or MIS receptor type II gene, our findings support the hypothesis that causative mutations of the MIS and the MIS receptor type II genes are rare in Japanese women with idiopathic POF and PCOS. The authors thank the Central Research Laboratory of Shiga University of Medical Science for sequencing analysis.